<html>
<head>PUBMED IDs for HLA-L</head>
<body bgcolor='#C5F0F2'><h1>HLA-L</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16866898/'>A novel HLA-B70 (B*9514) allele with an amino acid substitution (alanine to glycine at protein position 139) in a Caucasian heart allograft recipient.</a> July 27  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16893386/'>A novel HLA-A*0119 allele of a Caucasian family containing a mutation in a highly conserved region.</a> August 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17627756/'>A novel HLA-A*29 allele (A*2916) of a Caucasian relative to an ALL patient containing a point mutation in a putatively conserved region which was identified through the loss of a specific amplificate in a low-resolution SSP-PCR kit.</a> July 14  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18194362/'>A novel HLA-B*57 (B*5714) allele in a healthy male Caucasian individual.</a> January 16  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/27250585/'>Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia.</a> May 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28184970/'>Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls.</a> February 11  2017<br></body></html>
